(Reuters) – Japan’s Otsuka Pharmaceutical said on Wednesday it will stop development of its experimental drug to treat patients with agitation associated with Alzheimer’s disease.
(Reporting by Mariam Sunny in Bengaluru; Editing by Maju Samuel)
(Reuters) – Japan’s Otsuka Pharmaceutical said on Wednesday it will stop development of its experimental drug to treat patients with agitation associated with Alzheimer’s disease.
(Reporting by Mariam Sunny in Bengaluru; Editing by Maju Samuel)
Comments